- Home
- SYNA vs HCM Comparison
SYNA vs HCM Comparison
Compare SYNA & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYNA | HCM |
|---|---|---|
| Founded | 1986 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | 1811 |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYNA | HCM |
|---|---|---|
| Price | $73.21 | $13.99 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 9 | 1 |
| Target Price | ★ $100.78 | $13.75 |
| AVG Volume (30 Days) | ★ 586.5K | 20.0K |
| Earning Date | 05-07-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $663,588,000.00 | N/A |
| Revenue This Year | $12.63 | $28.37 |
| Revenue Next Year | $9.67 | $17.50 |
| P/E Ratio | ★ N/A | $5.49 |
| Revenue Growth | ★ 21.04 | N/A |
| 52 Week Low | $41.80 | $11.51 |
| 52 Week High | $97.00 | $19.50 |
Technical Indicators
Market Signals| Indicator | SYNA | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 40.25 | 45.45 |
| Support Level | $71.55 | $13.09 |
| Resistance Level | $81.85 | $14.80 |
| Average True Range (ATR) | 3.04 | 0.34 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 34.56 | 34.69 |
Price Performance
Historical ComparisonAbout SYNA Synaptics Incorporated $0.001 Par Value
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.